Search

Your search keyword '"Sarode, Karan"' showing total 14 results
Start Over Author "Sarode, Karan" Publisher elsevier b.v.
14 results on '"Sarode, Karan"'

2. Drug Delivering Technology for Endovascular Management of Infrainguinal Peripheral Artery Disease.

Author

Sarode, Karan, Spelber, David A., Bhatt, Deepak L., Mohammad, Atif, Prasad, Anand, Brilakis, Emmanouil S., and Banerjee, Subhash

Abstract

Endovascular intervention has become a well-recognized treatment modality for peripheral artery disease; however, mid- and long-term outcomes have been plagued by limited durability. Plain balloon angioplasty and bare-metal stents have historically suffered from high restenosis rates leading to the need for frequent repeat revascularization procedures. The innovation of locally administered, drug-delivering balloons and stents has been a direct result of technological innovations directed toward prevention and treatment of this limitation. Over the last 5 years, numerous clinical trials investigating the use of drug-coated stents and drug-coated balloons indicate a significant improvement in endovascular treatment durability and outcomes. This review provides an up-to-date assessment of the current evidence for the use of drug-coated stents and drug-coated balloons in the treatment of femoropopliteal and infrapopliteal peripheral artery disease. Additionally, it provides an overview of the development of this technology, highlights landmark ongoing and completed clinical trials, examines evidence to support the use of drug-coated technologies in combination with other modalities, and examines promising new technological developments. Last, it summarizes the challenges and safety concerns that have delayed U.S. Food and Drug Administration approval of these devices. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

6. CONTRAST MEDIA USE DURING ENDOVASCULAR THERAPY FOR INFRAINGUINAL PERIPHERAL ARTERIAL DISEASE: INSIGHTS FROM THE MULTI-CENTER XLPAD REGISTRY.

Author

Prasad, Anand, Sarode, Karan, Mohammad, Atif, Brilakis, Emmanouil, Gigliotti, Osvaldo, Luna, Michael, Addo, Tayo, Baig, Mirza, Shammas, Nicolas, Abu-Fadel, Mazen, Ortiz-Lopez, Carolina, Spelber, David, Esparza, Maria, Tsai, Shirling, and Banerjee, Subhash

Subjects
*ARTERIAL disease treatment, *CONTRAST media, *ENDOVASCULAR surgery, *KIDNEY injuries, *PEOPLE with diabetes, *INTERMITTENT claudication, *INJURY risk factors
Published
2015
Full Text
View/download PDF

7. EXPERIENCE TREATING IN-STENT RESTENOSIS LESIONS FROM A MULTICENTER REGISTRY.

Author

Banerjee, Subhash, Sarode, Karan, Mohammad, Atif, Gigliotti, Osvaldo, Luna, Michael, Addo, Tayo, Baig, Mirza, Tsai, Shirling, Shammas, Nicolas, Prasad, Anand, Abu-Fadel, Mazen, Klein, Andrew, and Brilakis, Emmanouil

Subjects
*CORONARY restenosis, *MEDICAL registries, *MEDICAL statistics, *CARDIAC surgery, *TISSUE wounds, *THERAPEUTICS
Published
2015
Full Text
View/download PDF

8. CRT-213 Comparison of Revascularization Outcomes for Patients with Lifestyle Limiting Claudication to Critical Limb Ischemia.

Author

Das, Swagata, Mohammad, Atif, Sarode, Karan, Pershwitz, Gene, Hadidi, Omar, Thomas, Rahul, Vinas, Ariel, Abu-Fadel, Mazen, Dieter, ROBERT.S., Ali, Mir Ishti, Shammas, Nicolas, Prasad, Anand, Gigliotti, Oswaldo, Klein, Andrew, Raffoul, Jad, Kumbhani, Dharam, Mody, Purav, Baig, Shadman, Kinlay, Scott, and Brilakis, Emmanouil

Published
2014
Full Text
View/download PDF

13. Significance of an Abnormal Ankle-Brachial Index in Patients With Established Coronary Artery Disease With and Without Associated Diabetes Mellitus.

Author

Banerjee, Subhash, Vinas, Ariel, Mohammad, Atif, Hadidi, Omar, Thomas, Rahul, Sarode, Karan, Banerjee, Avantika, Garg, Puja, Weideman, Rick A., Little, Bertis B., and Brilakis, Emmanouil S.

Subjects
*ANKLE brachial index, *CORONARY heart disease treatment, *PEOPLE with diabetes, *MYOCARDIAL infarction, *REVASCULARIZATION (Surgery), *CARDIOVASCULAR diseases risk factors, *PATIENTS
Abstract

An abnormal ankle-brachial index (ABI) is associated with higher risk for future cardiovascular (CV) events; however, it is unknown whether this association is true in patients with established coronary artery disease (CAD) and associated diabetes mellitus (DM). We evaluated 679 patients with stable CAD enrolled in the Excellence in Peripheral Arterial Disease and Veterans Affairs North Texas Healthcare System peripheral arterial disease databases. ABI and 12-month major adverse CV events (MACEs, a composite of all-cause death, nonfatal myocardial infarction, need for repeat coronary revascularization, and ischemic stroke) were assessed. Cox proportional hazard models were used to assess the association of ABI and DM with subsequent CV events. An abnormal ABI (<0.9 or >1.4) was present in 72% of patients with stable CAD and 68% had DM. Using patients without DM and normal ABI as reference, the adjusted hazard ratio for 12-month MACE was 1.7 (95% confidence interval [CI] 0.71 to 4.06) for patients with DM and normal ABI; 2.03 (95% CI 0.83 to 4.9) for patients without DM with abnormal ABI; and 4.85 (95% CI 2.22 to 10.61) for patients with DM and abnormal ABI. In conclusion, in patients with stable CAD, an abnormal ABI confers an incremental risk of MACE in addition to DM and traditional CV risk factors. [ABSTRACT FROM AUTHOR]

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results